A clonal crayfish from nature as a model for tumors

A genome study has proven that all specimen of Marmorkrebs, or marbled crayfish, originate from a single female. About 30 years ago, the original clone evolved in an aquarium. Ever since, the female animals have been able to spread successfully and massively without any help from males, scientists from the German Cancer Research Center (DKFZ) report in a current publication. The clonal genome evolution of the crayfish may also help explain processes in tumors.

Some years ago, a freshwater crayfish which reproduced alone in the aquarium puzzled pet owners and scientists. This could only be explained by a phenomenon called parthenogenesis, a natural form of asexual reproduction. Now, genome sequencing and comparative studies of individual animals have shown that in fact all specimen descend from a single mother crayfish. The Marmorkrebs clone is a separate species (Procambarus virginalis), which, as genetic studies have shown, has split from the slough crayfish found in the Everglades (Procambarus fallax) some 30 years ago.

In a current publication, Frank Lyko and his team from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg have provided proof that the all-female offspring of the marbled crayfish is genetically identical. Lyko explains: "We could detect only a few hundred variants in a genome that is larger than the human genome. That is an incredibly small number." The minute variations can be ascribed to natural mutations. The DKFZ researchers counted 3.5 billion base pairs in the crayfish genome, which makes it about seven percent larger than the human genome.

In another part of the study, a scientist in Madagascar additionally examined how well the crayfish is able to spread in the wild via parthenogenesis. Its enormous reproductive success came as a surprise to the scientists. "It was known that the crayfish can establish itself in the wild after releases from the aquarium," Lyko said. "But the news was that it can spread so rapidly and massively."

Apart from subtropical Madagascar, Marmorkrebs can also be found, for example, in Sweden, Japan, Freiburg, Hanover, or Heidelberg. This is evidence of its remarkable adaptability -without any sexual reproduction. According to textbook knowledge, it is precisely the "invention of sex" and the resulting mix of paternal and maternal genes that enlarge genetic variety, thus facilitating rapid adaptation to adverse environmental conditions.

However, although all marbled crayfish are born with the same genes, they are able to adapt to a wide variety of habitats. This is made possible by epigenetic mechanisms. These are regulated by small chemical tags attached to DNA, the genetic substance. Epigenetic mechanisms basically regulate the interpretation of genetic information. They work like switches that turn genes on or off. "Epigenetic variants are often influenced by genetic variants. In Marmorkrebs, however, epigenetic variation is independent, because there is virtually no genetic variation," Lyko explained.

This epigenetic regulation makes the marbled crayfish extremely interesting for tumor researchers. A crayfish for cancer research – what sounds like a play of words in German ("Krebs" is the word for the disease and also for 'crayfish'), has in fact become reality. Lyko said: "Marmorkrebs is an animal that reproduces clonally and therefore represents a model of a central aspect in tumor development." A tumor is also capable of adapting to its environment, for example, by developing resistance against anticancer drugs. Scientists have known for a couple of years, partly from studies at the DKFZ, that epigenetic mechanisms also play a key role in these processes. They can influence cancer risk and the disease course.

A phenomenon called clonal evolution occurs both in Marmorkrebs and in tumors. Lyko: "Tumor genomes also evolve clonally, because they go back to a single original cell." A variety of factors play a role in this process, such as chance mutations in genes, genetic drift, selective pressure and epigenetic adaptation to the environment. The team led by Lyko now wants to use marbled crayfish to further investigate their role. According to Julian Gutekunst, who is the first author of the present publication, the key question to be pursued is "which impact environmental factors have on epigenetics and gene regulation." These findings may enlarge our knowledge about processes in tumors and open prospects for new approaches in tumor treatment.

###

Julian Gutekunst, Ranja Andriantsoa, Cassandra Falckenhayn, Katharina Hanna, Wolfgang Stein, Jeanne Rasamy and Frank Lyko: Clonal genome evolution and rapid invasive spread of the marbled crayfish.

Nature Ecology & Evolution DOI: 10.1038/s41559-018-0467-910.1038/s41559-018-

A picture of the marbled crayfish is available for download: http://www.dkfz.de/de/presse/pressemitteilungen/2018/bilder/holotype.jpg

Note on use of images related to press releases

Use is free of charge. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) permits one-time use in the context of reporting about the topic covered in the press release. Images have to be cited as follows: "Source: Frank Lyko, DKFZ".

Distribution of images to third parties is not permitted unless prior consent has been obtained from DKFZ's Press Office (phone: ++49-(0)6221 42 2854, E-mail: [email protected]). Any commercial use is prohibited.

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center is an important contribution to improving the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.

Media Contact

Dr. Sibylle Kohlstädt
[email protected]
@DKFZ

http://www.dkfz.de

http://dx.doi.org/10.1038/s41559-018-0467-910.10

Comments
%d bloggers like this: